Latest News and Press Releases

The partnership will combine technological innovation and operational expertise to build more efficient and patient-centered chronic disease service.

Fangzhou presented its innovative “AI+Chronic Disease Service” solutions, addressing some of the most pressing challenges in chronic disease care.

The report highlights strong revenue growth, a return to full-year profitability and continued execution of Fangzhou’s “AI + chronic care” strategy.

Mr. Wang succeeds former CEO Mr. Xie Fangmin and steps into the leadership role following a milestone year for the Company.

Fangzhou reported its 2025 annual results, posting strong revenue growth and achieving full-year profitability.

The partnership aims to accelerate the digital transformation and enhancement of chronic disease services through the application of AI.

GUANGZHOU, China, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, received prominent...

The XS LLM integrates five intelligent agents into a closed-loop system covering the full chronic disease management cycle.

Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care.

Fangzhou expects full-year revenue for 2025 to reach between RMB 3.5 billion and RMB 3.55 billion, representing year-on-year growth of approximately 30%